Cargando…

A new approach for COVID-19 treatment by micro-RNA

MicroRNAs (miRNAs) naturally occur in plants and all living organisms. They play an important role in gene regulation through binding toa specific region in open reading frames (ORFs) and/or untranslated regions (UTRs) to block the translation processes through either degrading or blocking mRNA resu...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Nabi, Sobhy Hassab, Elhiti, Mohamed, El-Sheekh, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435294/
https://www.ncbi.nlm.nih.gov/pubmed/33017912
http://dx.doi.org/10.1016/j.mehy.2020.110203
_version_ 1783572309694480384
author El-Nabi, Sobhy Hassab
Elhiti, Mohamed
El-Sheekh, Mostafa
author_facet El-Nabi, Sobhy Hassab
Elhiti, Mohamed
El-Sheekh, Mostafa
author_sort El-Nabi, Sobhy Hassab
collection PubMed
description MicroRNAs (miRNAs) naturally occur in plants and all living organisms. They play an important role in gene regulation through binding toa specific region in open reading frames (ORFs) and/or untranslated regions (UTRs) to block the translation processes through either degrading or blocking mRNA resulting in knocking down or suppression of targeted genes. Plants and many organisms protect themselves from viruses through the production of miRNAs, which are complementary to 3UTR of viruses resulting in degrading the viral mRNA or block the translation on ribosomes. As pandemic, COVID-19, and its consequences on the global economy, we hypothesized a new approach for the treatment of COVID-19 paints. This approach includes designing a mix of miRNAs targeting several regions on COVID-19 open reading frame (ORF) and 3 UTR and suitable delivery system targeting respiratory system tissues. These synthesized miRNAs may be delivered to humansinnon-viral delivery systems such as liposomes like exosome (extracellular vesicle), polymer-based carriers, or inorganic nanoparticles, which are considered to be more suitable for human use.
format Online
Article
Text
id pubmed-7435294
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74352942020-08-19 A new approach for COVID-19 treatment by micro-RNA El-Nabi, Sobhy Hassab Elhiti, Mohamed El-Sheekh, Mostafa Med Hypotheses Letter to Editors MicroRNAs (miRNAs) naturally occur in plants and all living organisms. They play an important role in gene regulation through binding toa specific region in open reading frames (ORFs) and/or untranslated regions (UTRs) to block the translation processes through either degrading or blocking mRNA resulting in knocking down or suppression of targeted genes. Plants and many organisms protect themselves from viruses through the production of miRNAs, which are complementary to 3UTR of viruses resulting in degrading the viral mRNA or block the translation on ribosomes. As pandemic, COVID-19, and its consequences on the global economy, we hypothesized a new approach for the treatment of COVID-19 paints. This approach includes designing a mix of miRNAs targeting several regions on COVID-19 open reading frame (ORF) and 3 UTR and suitable delivery system targeting respiratory system tissues. These synthesized miRNAs may be delivered to humansinnon-viral delivery systems such as liposomes like exosome (extracellular vesicle), polymer-based carriers, or inorganic nanoparticles, which are considered to be more suitable for human use. Elsevier Ltd. 2020-10 2020-08-19 /pmc/articles/PMC7435294/ /pubmed/33017912 http://dx.doi.org/10.1016/j.mehy.2020.110203 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to Editors
El-Nabi, Sobhy Hassab
Elhiti, Mohamed
El-Sheekh, Mostafa
A new approach for COVID-19 treatment by micro-RNA
title A new approach for COVID-19 treatment by micro-RNA
title_full A new approach for COVID-19 treatment by micro-RNA
title_fullStr A new approach for COVID-19 treatment by micro-RNA
title_full_unstemmed A new approach for COVID-19 treatment by micro-RNA
title_short A new approach for COVID-19 treatment by micro-RNA
title_sort new approach for covid-19 treatment by micro-rna
topic Letter to Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435294/
https://www.ncbi.nlm.nih.gov/pubmed/33017912
http://dx.doi.org/10.1016/j.mehy.2020.110203
work_keys_str_mv AT elnabisobhyhassab anewapproachforcovid19treatmentbymicrorna
AT elhitimohamed anewapproachforcovid19treatmentbymicrorna
AT elsheekhmostafa anewapproachforcovid19treatmentbymicrorna
AT elnabisobhyhassab newapproachforcovid19treatmentbymicrorna
AT elhitimohamed newapproachforcovid19treatmentbymicrorna
AT elsheekhmostafa newapproachforcovid19treatmentbymicrorna